5 Best Stocks To Buy According to Billionaire Larry Robbins

In this article, we discuss the 5 best stocks to buy according to billionaire Larry Robbins. If you want our detailed analysis of these stocks, go directly to 10 Best Stocks To Buy According to Billionaire Larry Robbins. 

5. AmerisourceBergen Corporation (NYSE:ABC)

Glenview Capital’s Stake Value: $225,283,000

Percentage of Glenview Capital’s 13F Portfolio: 4.12%

Number of Hedge Fund Holders: 44

Billionaire Larry Robbins owns a $225.2 million stake in AmerisourceBergen Corporation (NYSE:ABC) as of September 2021, and the stock represents 4.12% of his total third quarter investments. AmerisourceBergen Corporation (NYSE:ABC) is an American wholesale company providing pharmaceutical drugs and pharmacy services. 

Deutsche Bank analyst George Hill on November 12 raised the price target on AmerisourceBergen Corporation (NYSE:ABC) to $153 from $136 and kept a Hold rating on the shares after the “modest beat” in the third quarter.

Suvretta Capital Management is the largest AmerisourceBergen Corporation (NYSE:ABC) stakeholder, with 1.2 million shares, worth $147.5 million. Overall, 44 hedge funds held stakes in AmerisourceBergen Corporation (NYSE:ABC) during the third quarter of 2021.

Here is what Heartland Advisors has to say about AmerisourceBergen Corporation (NYSE:ABC) in its Q3 2021 investor letter:

“The ABCs of quality.AmerisourceBergen Corp. (ABC), a leading national pharmaceutical distributor, provides an example of our approach. The company has been quietly bolstering its business model during the past few years to include animal health products for the European market and an expanded line of higher-margin, value-added services that reach beyond drug distribution. During these efforts, valuations for the company have been under pressure due to liability issues stemming from opioid litigation as well as concerns about increased scrutiny of drug prices by politicians.

Our team has been following these developments and believes the strides management has made on the business side are not being fully recognized by the market. As more clarity has emerged related to opioid litigation, we’ve increased the portfolio’s stake in AmerisourceBergen and believe the investment provides the portfolio with additional exposure to a high-quality business that is well positioned to grow despite operating in a mature industry.”